BNR vs. SSNT, ABLV, ALLT, FAAS, OCFT, RCAT, CNGL, DOMA, SCOR, and ARQQ
Should you be buying Burning Rock Biotech stock or one of its competitors? The main competitors of Burning Rock Biotech include SilverSun Technologies (SSNT), Able View Global (ABLV), Allot Communications (ALLT), DigiAsia (FAAS), OneConnect Financial Technology (OCFT), Red Cat (RCAT), Canna-Global Acquisition (CNGL), Doma (DOMA), comScore (SCOR), and Arqit Quantum (ARQQ). These companies are all part of the "business services" sector.
Burning Rock Biotech (NASDAQ:BNR) and SilverSun Technologies (NASDAQ:SSNT) are both small-cap business services companies, but which is the superior investment? We will contrast the two companies based on the strength of their community ranking, valuation, profitability, earnings, risk, analyst recommendations, institutional ownership, media sentiment and dividends.
SilverSun Technologies received 155 more outperform votes than Burning Rock Biotech when rated by MarketBeat users. Likewise, 59.04% of users gave SilverSun Technologies an outperform vote while only 31.25% of users gave Burning Rock Biotech an outperform vote.
SilverSun Technologies has lower revenue, but higher earnings than Burning Rock Biotech. SilverSun Technologies is trading at a lower price-to-earnings ratio than Burning Rock Biotech, indicating that it is currently the more affordable of the two stocks.
SilverSun Technologies has a net margin of -1.96% compared to Burning Rock Biotech's net margin of -121.79%. SilverSun Technologies' return on equity of -12.38% beat Burning Rock Biotech's return on equity.
30.0% of Burning Rock Biotech shares are held by institutional investors. Comparatively, 58.7% of SilverSun Technologies shares are held by institutional investors. 30.3% of Burning Rock Biotech shares are held by insiders. Comparatively, 37.8% of SilverSun Technologies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.
Burning Rock Biotech has a beta of 0.23, suggesting that its stock price is 77% less volatile than the S&P 500. Comparatively, SilverSun Technologies has a beta of 2.14, suggesting that its stock price is 114% more volatile than the S&P 500.
In the previous week, SilverSun Technologies had 1 more articles in the media than Burning Rock Biotech. MarketBeat recorded 1 mentions for SilverSun Technologies and 0 mentions for Burning Rock Biotech. SilverSun Technologies' average media sentiment score of 0.59 beat Burning Rock Biotech's score of 0.00 indicating that SilverSun Technologies is being referred to more favorably in the news media.
Summary
SilverSun Technologies beats Burning Rock Biotech on 13 of the 15 factors compared between the two stocks.
Get Burning Rock Biotech News Delivered to You Automatically
Sign up to receive the latest news and ratings for BNR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding BNR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Burning Rock Biotech Competitors List
Related Companies and Tools
